High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients
Launched by ZHEJIANG UNIVERSITY ·
Trial Information
Current as of October 03, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using a special type of oxygen delivery called High-Flow Nasal Cannula (HFNC) can help prevent low oxygen levels (hypoxia) in patients with a high risk of sleep apnea during sedated gastrointestinal procedures, like endoscopy. Sleep apnea is a condition that can make it harder to breathe, especially when sedated, and this study focuses on patients who score 5 or higher on a common sleep apnea screening test called STOP-BANG, meaning they are more likely to have breathing problems during the procedure.
The study is looking for adults between 65 and 74 years old who are undergoing sedated endoscopy and are considered high risk for sleep apnea. Participants can expect to receive oxygen through the HFNC during their procedure to see if it helps keep their oxygen levels stable. This research is important because preventing low oxygen during sedation can make these procedures safer for people with sleep apnea. The study is not yet recruiting, but it welcomes men and women who meet the criteria.
Gender
ALL
Eligibility criteria
About Zhejiang University
Zhejiang University is a prestigious research institution located in Hangzhou, China, renowned for its commitment to advancing medical science and healthcare innovation. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university plays a pivotal role in the development and execution of clinical trials aimed at improving patient outcomes and enhancing therapeutic approaches. Leveraging its extensive resources and expertise, Zhejiang University is dedicated to fostering advancements in medical knowledge while ensuring the highest standards of ethical conduct and scientific rigor in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported